Pharmaceutical
China Encourages Innovative Drug R&D in Draft of Regulations for Implementing DAL, 2022
On May 9, China National Medical Products Administration (NMPA) released the draft of the revised Regulations for Implementation of the Drug Administration Law (hereafter referred to as ...
2022-05-20